Key facts
- Scripta Insights’s last known valuation is $83.0M.
- It has raised $43.7M across 1 recorded rounds; the latest was Early Stage VC ($16.7M) in Dec 2024.
- Notable investors include Western Technology Investment, Pillar VC, CEAS Investments I, Contour Venture Partners, Aquiline (New York) — 9 tracked in total.
- Scripta Insights has filed 1 Form D with the SEC, most recently Feb 2025 ($16.7M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Scripta Insights
Funding rounds
1 roundsAbout Scripta Insights
Developer of a cloud-based healthcare information technology platform designed for precise drug pricing prescription. The company's platform analyzes every pharmacy benefit manager transaction, monitors benefits spending on an ongoing basis, assists in cost-control and vigilance, and also compares them to contracts, enabling employers, consultants, health plans, and members to identify unnecessary over-spending, save from medicines and also avail online pharmacy benefits.
- Sector
- Healthcare
- HQ
- Wellesley, MA, United States
- Founded
- 2008
- Employees
- 71
- Website
- scriptainsights.com/
- Ownership
- Privately Held (backing)
Scripta Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scripta Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scripta Insights in its N-PORT filings yet. We sweep new filings monthly.